CAV3 alleviates diabetic cardiomyopathy via inhibiting NDUFA10-mediated mitochondrial dysfunction

Ping Guo,Shuiqing Hu,Xiaohui Liu,Miaomiao He,Jie Li,Tingqiong Ma,Man Huang,Qin Fang,Yan Wang
DOI: https://doi.org/10.1186/s12967-024-05223-6
IF: 8.44
2024-04-27
Journal of Translational Medicine
Abstract:The progression of diabetic cardiomyopathy (DCM) is noticeably influenced by mitochondrial dysfunction. Variants of caveolin 3 (CAV3) play important roles in cardiovascular diseases. However, the potential roles of CAV3 in mitochondrial function in DCM and the related mechanisms have not yet been elucidated.
medicine, research & experimental
What problem does this paper attempt to address?